AP1828A - Muscarinic Acetycholine receptor antagonists - Google Patents

Muscarinic Acetycholine receptor antagonists

Info

Publication number: AP1828A
Authority: AP; ARIPO
Prior art keywords: receptor antagonists; acetycholine receptor; muscarinic; muscarinic acetycholine; antagonists
Prior art date: 2003-10-14

Application number

AP2006003566A

Other languages

English (en)

Other versions

AP2006003566A0 (en

Inventor

Michael R Palovich

Jakob Busch-Petersen

Zehong Wan

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-14

Filing date

2004-10-12

Publication date

2008-02-13

2004-10-12 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2006-04-30 Publication of AP2006003566A0 publication Critical patent/AP2006003566A0/xx

2008-02-13 Application granted granted Critical

2008-02-13 Publication of AP1828A publication Critical patent/AP1828A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AP2006003566A 2003-10-14 2004-10-12 Muscarinic Acetycholine receptor antagonists AP1828A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51100903P	2003-10-14	2003-10-14
PCT/US2004/033638 WO2005037280A1 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists

Publications (2)

Publication Number	Publication Date
AP2006003566A0 AP2006003566A0 (en)	2006-04-30
AP1828A true AP1828A (en)	2008-02-13

Family

ID=34465175

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AP2007004239A AP2007004239A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists
AP2007004238A AP2007004238A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists
AP2006003566A AP1828A (en)	2003-10-14	2004-10-12	Muscarinic Acetycholine receptor antagonists

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
AP2007004239A AP2007004239A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists
AP2007004238A AP2007004238A0 (en)	2003-10-14	2004-10-12	Muscarinic acetycholine receptor antagonists

Country Status (34)

Country	Link
US (3)	US7276521B2 (xx)
EP (1)	EP1677795B1 (xx)
JP (4)	JP2007508390A (xx)
KR (3)	KR20080065318A (xx)
CN (3)	CN1893948A (xx)
AP (3)	AP2007004239A0 (xx)
AR (1)	AR046103A1 (xx)
AT (1)	ATE494285T1 (xx)
AU (1)	AU2004281724B2 (xx)
BR (1)	BRPI0415361A (xx)
CA (1)	CA2542657C (xx)
CY (1)	CY1111364T1 (xx)
DE (1)	DE602004030930D1 (xx)
DK (1)	DK1677795T3 (xx)
EA (3)	EA013435B1 (xx)
EC (1)	ECSP066468A (xx)
ES (1)	ES2358673T3 (xx)
HR (1)	HRP20110232T1 (xx)
IL (2)	IL174843A0 (xx)
IS (1)	IS2918B (xx)
MA (1)	MA28110A1 (xx)
MX (1)	MXPA06004244A (xx)
MY (1)	MY143366A (xx)
NO (1)	NO20062042L (xx)
NZ (2)	NZ546312A (xx)
OA (1)	OA13316A (xx)
PE (1)	PE20050963A1 (xx)
PL (1)	PL1677795T3 (xx)
PT (1)	PT1677795E (xx)
SG (1)	SG147436A1 (xx)
SI (1)	SI1677795T1 (xx)
TW (3)	TW200811171A (xx)
UA (2)	UA89734C2 (xx)
WO (1)	WO2005037280A1 (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20050250A1 (es) *	2003-07-17	2005-04-08	Glaxo Group Ltd	Antagonistas de los receptores muscarinicos de la acetilcolina
EA013435B1 (ru)	2003-10-14	2010-04-30	Глэксо Груп Лимитед	Антагонисты мускариновых ацетилхолиновых рецепторов
BRPI0415281A (pt) *	2003-10-17	2006-12-19	Glaxo Group Ltd	antagonistas de receptor de acetilcolina muscarìnico
AR046225A1 (es) *	2003-11-04	2005-11-30	Glaxo Group Ltd	Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
EP1725236A4 (en) *	2004-03-11	2009-05-13	Glaxo Group Ltd	NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
WO2005094251A2 (en) *	2004-03-17	2005-10-13	Glaxo Group Limited	M3muscarinic acetylcholine receptor antagonists
EP1725564A4 (en) *	2004-03-17	2007-09-12	Glaxo Group Ltd	ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR
TWI363759B (en)	2004-04-27	2012-05-11	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
EP1747219A4 (en) *	2004-05-13	2010-05-26	Glaxo Group Ltd	Antagonists of muscarinic acetylcholine receptor
US7932247B2 (en) *	2004-11-15	2011-04-26	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US20080275079A1 (en) *	2005-08-02	2008-11-06	Glaxo Group Limited	M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007022351A2 (en) *	2005-08-18	2007-02-22	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
MX2008013411A (es)	2006-04-20	2008-11-04	Glaxo Group Ltd	Nuevos compuestos.
GB0611587D0 (en)	2006-06-12	2006-07-19	Glaxo Group Ltd	Novel compounds
PL2046787T3 (pl)	2006-08-01	2011-10-31	Glaxo Group Ltd	Związki pirazolo[3,4-b]pirydynowe i ich zastosowanie jako inhibitory PDE4
EP2094643B1 (en) *	2006-12-01	2012-02-29	Bristol-Myers Squibb Company	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
PE20081889A1 (es)	2007-03-23	2009-03-05	Smithkline Beecham Corp	Indol carboxamidas como inhibidores de ikk2
BRPI0816255A2 (pt) *	2007-09-12	2015-03-17	Glaxo Group Ltd	Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
AR070564A1 (es)	2008-02-06	2010-04-21	Glaxo Group Ltd	Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden
TW201000476A (en)	2008-02-06	2010-01-01	Glaxo Group Ltd	Dual pharmacophores-PDE4-muscarinic antagonistics
UY31636A1 (es)	2008-02-06	2009-08-03		Farmacoforos duales-antagonistas muscarinicos de pde4
JP5502077B2 (ja)	2008-06-05	2014-05-28	グラクソグループリミテッド	新規な化合物
ES2566339T3 (es)	2008-06-05	2016-04-12	Glaxo Group Limited	Derivados de 4-carboxamida indazol útiles como inhibidores de PI3-quinasas
WO2010094643A1 (en)	2009-02-17	2010-08-26	Glaxo Group Limited	Quinoline derivatives and their uses for rhinitis and urticaria
WO2010097114A1 (en) *	2009-02-26	2010-09-02	Glaxo Group Limited	Novel combination of therapeutic agents
JP5809985B2 (ja)	2009-02-26	2015-11-11	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	４−｛（１ｒ）−２−［（６−｛２−［（２，６−ジクロロベンジル）オキシ］エトキシ｝ヘキシル）アミノ］−１−ヒドロキシエチル｝−２−（ヒドロキシメチル）フェノールを含む医薬製剤
WO2010102958A1 (en)	2009-03-09	2010-09-16	Glaxo Group Limited	4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
JP2012520257A (ja)	2009-03-10	2012-09-06	グラクソグループリミテッド	Ｉｋｋ２阻害剤としてのインドール誘導体
JP2012520845A (ja)	2009-03-17	2012-09-10	グラクソグループリミテッド	Ｉｔｋ阻害剤として使用されるピリミジン誘導体
KR101679642B1 (ko)	2009-04-30	2016-11-25	글락소 그룹 리미티드	Ｐｉ3키나아제 억제제로서 옥사졸 치환된 인다졸
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
US20120238559A1 (en)	2009-12-03	2012-09-20	Glaxo Group Limited	Novel compounds
WO2011067365A1 (en)	2009-12-03	2011-06-09	Glaxo Group Limited	Benzpyrazole derivatives as inhibitors of p13 kinases
US20120238571A1 (en)	2009-12-03	2012-09-20	Glaxo Group Limited	Indazole derivatives as pi 3-kinase
WO2011110575A1 (en)	2010-03-11	2011-09-15	Glaxo Group Limited	Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
JP5965402B2 (ja)	2010-09-08	2016-08-03	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	Ｎ−［５−［４−（５−｛［（２ｒ，６ｓ）−２，６−ジメチル−４−モルホリニル］メチル｝−１，３−オキサゾール−２−イル）−１ｈ−インダゾール−６−イル］−２−（メチルオキシ）−３−ピリジニル］メタンスルホンアミドの多形体および塩
WO2012035055A1 (en)	2010-09-17	2012-03-22	Glaxo Group Limited	Novel compounds
GB201018124D0 (en)	2010-10-27	2010-12-08	Glaxo Group Ltd	Polymorphs and salts
US9763965B2 (en)	2012-04-13	2017-09-19	Glaxosmithkline Intellectual Property Development Limited	Aggregate particles
GB201222679D0 (en)	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
WO2015055691A1 (en)	2013-10-17	2015-04-23	Glaxosmithkline Intellectual Property Development Limited	Pi3k inhibitor for treatment of respiratory disease
EP3057587A1 (en)	2013-10-17	2016-08-24	GlaxoSmithKline Intellectual Property Development Limited	Pi3k inhibitor for treatment of respiratory disease
TW201625247A (zh)	2014-05-12	2016-07-16	葛蘭素史密斯克藍智慧財產權有限公司	用於治療傳染性疾病之醫藥組合物
GB201602527D0 (en)	2016-02-12	2016-03-30	Glaxosmithkline Ip Dev Ltd	Chemical compounds
EP3497100A1 (en)	2016-08-08	2019-06-19	GlaxoSmithKline Intellectual Property Development Limited	Chemical compounds
GB201706102D0 (en)	2017-04-18	2017-05-31	Glaxosmithkline Ip Dev Ltd	Chemical compounds
GB201712081D0 (en)	2017-07-27	2017-09-13	Glaxosmithkline Ip Dev Ltd	Chemical compounds
CN116194114A (zh)	2020-03-26	2023-05-30	葛兰素史密斯克莱知识产权发展有限公司	用于防止或治疗病毒感染的组织蛋白酶抑制剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2800481A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2800482A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (de)	1967-06-08	1972-04-25	Siemens Ag	Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens
GB2064336B (en)	1979-12-06	1984-03-14	Glaxo Group Ltd	Device for dispensing medicaments
EP0069715B1 (en)	1981-07-08	1986-11-05	Aktiebolaget Draco	Powder inhalator
GB2169265B (en)	1982-10-08	1987-08-12	Glaxo Group Ltd	Pack for medicament
CA1224992A (en)	1982-10-08	1987-08-04	Robert E. Newell	Device for administering medicament to patients
CH672600A5 (xx)	1985-07-30	1989-12-15	Glaxo Group Ltd
IT1204826B (it)	1986-03-04	1989-03-10	Chiesi Farma Spa	Composizioni farmaceutiche per inalazione
GB8923590D0 (en) *	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
GB9000304D0 (en) *	1990-01-06	1990-03-07	Pfizer Ltd	Muscarinic receptor antagonists
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
DE4108393A1 (de) *	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
JP3294961B2 (ja) *	1993-12-10	2002-06-24	杏林製薬株式会社	新規イミダゾール誘導体及びその製造法
JPH08291141A (ja) *	1995-04-21	1996-11-05	Kotobuki Seiyaku Kk	ジフェニル酢酸誘導体及びその製造法
JPH0920758A (ja) *	1995-07-06	1997-01-21	Kyorin Pharmaceut Co Ltd	新規環状ジアミン誘導体及びその製造法
WO1998024788A1 (en) *	1996-12-02	1998-06-11	Georgetown University	Tropane derivatives and method for their synthesis
US6248752B1 (en) *	1998-02-27	2001-06-19	Charles Duane Smith	Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) *	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
KR20050030169A (ko) *	2001-10-17	2005-03-29	유씨비 소시에떼아노님	퀴누클리딘 유도체, 이의 제조 방법 및 ｍ2 및/또는 ｍ3무스카린 수용체 억제제로서의 이의 용도
US6696462B2 (en) *	2002-01-31	2004-02-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
DE10211700A1 (de) *	2002-03-16	2003-09-25	Boehringer Ingelheim Pharma	Neue Difurylglykolsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
PE20040892A1 (es)	2002-08-06	2004-11-19	Glaxo Group Ltd	Antagonistas del receptor muscarinico m3 de acetilcolina
US7232841B2 (en) *	2003-04-07	2007-06-19	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
AR045913A1 (es)	2003-07-17	2005-11-16	Glaxo Group Ltd	Derivados olefinicos de 8-azabiciclo[3,2,1]octanos como antagonistas de receptores muscarinicos de acetilcolina
AR048573A1 (es) *	2003-07-17	2006-05-10	Glaxo Group Ltd	Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima
PE20050250A1 (es) *	2003-07-17	2005-04-08	Glaxo Group Ltd	Antagonistas de los receptores muscarinicos de la acetilcolina
EA013435B1 (ru) *	2003-10-14	2010-04-30	Глэксо Груп Лимитед	Антагонисты мускариновых ацетилхолиновых рецепторов
AR046225A1 (es) *	2003-11-04	2005-11-30	Glaxo Group Ltd	Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
US7345060B2 (en)	2003-11-21	2008-03-18	Theravance, Inc.	Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
US20090258858A1 (en)	2004-10-29	2009-10-15	Jakob Busch-Petersen	Muscarinic acetylcholine receptor antagonists
US7932247B2 (en)	2004-11-15	2011-04-26	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
JP2008520573A (ja)	2004-11-15	2008-06-19	グラクソグループリミテッド	新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
PE20060826A1 (es)	2004-12-06	2006-10-08	Smithkline Beecham Corp	Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
PE20061162A1 (es)	2004-12-06	2006-10-14	Smithkline Beecham Corp	Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
WO2006065788A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Novel muscarinic acetylcholine receptor antagonists
WO2006065755A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetycholine receptor antagonists
WO2007018514A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2007016650A2 (en)	2005-08-02	2007-02-08	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US20080275079A1 (en)	2005-08-02	2008-11-06	Glaxo Group Limited	M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007022351A2 (en)	2005-08-18	2007-02-22	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists

2004
- 2004-10-12 EA EA200702617A patent/EA013435B1/ru not_active IP Right Cessation
- 2004-10-12 EA EA200702619A patent/EA013689B1/ru not_active IP Right Cessation
- 2004-10-12 UA UAA200900439A patent/UA89734C2/ru unknown
- 2004-10-12 KR KR1020087016101A patent/KR20080065318A/ko not_active Application Discontinuation
- 2004-10-12 CN CNA2004800372668A patent/CN1893948A/zh active Pending
- 2004-10-12 WO PCT/US2004/033638 patent/WO2005037280A1/en active Application Filing
- 2004-10-12 AP AP2007004239A patent/AP2007004239A0/xx unknown
- 2004-10-12 SG SG200807641-6A patent/SG147436A1/en unknown
- 2004-10-12 BR BRPI0415361-8A patent/BRPI0415361A/pt not_active Application Discontinuation
- 2004-10-12 DE DE602004030930T patent/DE602004030930D1/de not_active Expired - Lifetime
- 2004-10-12 AU AU2004281724A patent/AU2004281724B2/en not_active Ceased
- 2004-10-12 AR ARP040103693A patent/AR046103A1/es not_active Application Discontinuation
- 2004-10-12 TW TW096137867A patent/TW200811171A/zh unknown
- 2004-10-12 EA EA200600773A patent/EA009899B1/ru not_active IP Right Cessation
- 2004-10-12 JP JP2006535591A patent/JP2007508390A/ja active Pending
- 2004-10-12 DK DK04794886.4T patent/DK1677795T3/da active
- 2004-10-12 NZ NZ546312A patent/NZ546312A/en unknown
- 2004-10-12 PT PT04794886T patent/PT1677795E/pt unknown
- 2004-10-12 US US10/575,839 patent/US7276521B2/en not_active Expired - Fee Related
- 2004-10-12 PL PL04794886T patent/PL1677795T3/pl unknown
- 2004-10-12 EP EP04794886A patent/EP1677795B1/en not_active Expired - Lifetime
- 2004-10-12 NZ NZ556424A patent/NZ556424A/en unknown
- 2004-10-12 MY MYPI20044177A patent/MY143366A/en unknown
- 2004-10-12 TW TW093130797A patent/TWI409060B/zh not_active IP Right Cessation
- 2004-10-12 ES ES04794886T patent/ES2358673T3/es not_active Expired - Lifetime
- 2004-10-12 OA OA1200600122A patent/OA13316A/en unknown
- 2004-10-12 KR KR1020087016103A patent/KR20080067023A/ko not_active Application Discontinuation
- 2004-10-12 CA CA2542657A patent/CA2542657C/en not_active Expired - Fee Related
- 2004-10-12 MX MXPA06004244A patent/MXPA06004244A/es active IP Right Grant
- 2004-10-12 CN CNA2008100092898A patent/CN101230061A/zh active Pending
- 2004-10-12 AP AP2007004238A patent/AP2007004238A0/xx unknown
- 2004-10-12 AP AP2006003566A patent/AP1828A/xx active
- 2004-10-12 TW TW096137868A patent/TW200811172A/zh unknown
- 2004-10-12 AT AT04794886T patent/ATE494285T1/de active
- 2004-10-12 SI SI200431631T patent/SI1677795T1/sl unknown
- 2004-10-12 UA UAA200604113A patent/UA87473C2/ru unknown
- 2004-10-12 KR KR1020067007082A patent/KR20060106821A/ko not_active Application Discontinuation
- 2004-10-12 CN CNA2008100092900A patent/CN101230062A/zh active Pending
- 2004-10-12 PE PE2004000982A patent/PE20050963A1/es not_active Application Discontinuation
2006
- 2006-03-31 EC EC2006006468A patent/ECSP066468A/es unknown
- 2006-04-06 IL IL174843A patent/IL174843A0/en unknown
- 2006-04-25 MA MA28964A patent/MA28110A1/fr unknown
- 2006-05-05 IS IS8441A patent/IS2918B/is unknown
- 2006-05-08 NO NO20062042A patent/NO20062042L/no not_active Application Discontinuation
2007
- 2007-06-21 US US11/766,371 patent/US7576096B2/en not_active Expired - Fee Related
- 2007-06-21 US US11/766,318 patent/US7579361B2/en not_active Expired - Fee Related
- 2007-08-02 JP JP2007201718A patent/JP4796552B2/ja not_active Expired - Fee Related
- 2007-08-02 JP JP2007201719A patent/JP2007314567A/ja active Pending
- 2007-12-13 IL IL188112A patent/IL188112A/en not_active IP Right Cessation
2011
- 2011-03-30 CY CY20111100339T patent/CY1111364T1/el unknown
- 2011-03-31 HR HR20110232T patent/HRP20110232T1/hr unknown
- 2011-05-16 JP JP2011109756A patent/JP5450509B2/ja not_active Expired - Fee Related

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2800481A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof

Also Published As

Publication number	Publication date
AP2006003566A0 (en)	2006-04-30
EP1677795A1 (en)	2006-07-12
JP2007314567A (ja)	2007-12-06
MY143366A (en)	2011-04-29
EA013689B1 (ru)	2010-06-30
IL188112A0 (en)	2008-03-20
US7576096B2 (en)	2009-08-18
AP2007004238A0 (en)	2007-12-31
HRP20110232T1 (hr)	2011-05-31
JP2007277276A (ja)	2007-10-25
CN101230061A (zh)	2008-07-30
AP2007004239A0 (en)	2007-12-31
JP2011162556A (ja)	2011-08-25
EA200600773A1 (ru)	2008-04-28
EA200702619A1 (ru)	2008-04-28
KR20060106821A (ko)	2006-10-12
US20070244150A1 (en)	2007-10-18
US7579361B2 (en)	2009-08-25
ES2358673T3 (es)	2011-05-12
EA200702617A1 (ru)	2008-04-28
IL174843A0 (en)	2006-08-20
EA009899B1 (ru)	2008-04-28
IS2918B (is)	2015-01-15
TW200522933A (en)	2005-07-16
PT1677795E (pt)	2011-04-01
NZ546312A (en)	2008-09-26
UA87473C2 (xx)	2009-07-27
TWI409060B (zh)	2013-09-21
EP1677795A4 (en)	2006-12-27
JP5450509B2 (ja)	2014-03-26
CA2542657C (en)	2011-03-01
MA28110A1 (fr)	2006-08-01
TW200811171A (en)	2008-03-01
AR046103A1 (es)	2005-11-23
CA2542657A1 (en)	2005-04-28
KR20080065318A (ko)	2008-07-11
DK1677795T3 (da)	2011-04-18
BRPI0415361A (pt)	2006-12-12
SI1677795T1 (sl)	2011-04-29
CY1111364T1 (el)	2015-08-05
KR20080067023A (ko)	2008-07-17
WO2005037280A1 (en)	2005-04-28
NO20062042L (no)	2006-05-08
EA013435B1 (ru)	2010-04-30
IL188112A (en)	2012-10-31
IS8441A (is)	2006-05-05
SG147436A1 (en)	2008-11-28
US20070105895A1 (en)	2007-05-10
AU2004281724A1 (en)	2005-04-28
ATE494285T1 (de)	2011-01-15
OA13316A (en)	2007-04-13
JP2007508390A (ja)	2007-04-05
JP4796552B2 (ja)	2011-10-19
US20070238752A1 (en)	2007-10-11
EP1677795B1 (en)	2011-01-05
US7276521B2 (en)	2007-10-02
CN101230062A (zh)	2008-07-30
NZ556424A (en)	2008-12-24
MXPA06004244A (es)	2006-06-28
DE602004030930D1 (de)	2011-02-17
ECSP066468A (es)	2006-11-16
CN1893948A (zh)	2007-01-10
UA89734C2 (xx)	2010-02-25
PE20050963A1 (es)	2006-01-11
AU2004281724B2 (en)	2010-07-15
TW200811172A (en)	2008-03-01
PL1677795T3 (pl)	2011-05-31

Publication	Publication Date	Title
AP1828A (en)	2008-02-13	Muscarinic Acetycholine receptor antagonists
AU2003261392A8 (en)	2004-02-23	M3muscarinic acetylcholine receptor antagonists
HK1090922A1 (en)	2007-01-05	Cgrp receptor antagonists cgrp
SI1682142T1 (sl)	2012-10-30	Antagonisti M3 muskarinskega acetilholinskega receptorja
IL174846A0 (en)	2006-08-20	Muscarinic acetylcholine receptor antagonists
EP1553075A4 (en)	2009-11-04	LPA Receptor Antagonists
AU2003301851A1 (en)	2004-06-07	Azacyclic compounds as orexin receptor antagonist
EP1725238A4 (en)	2009-04-01	ACETYLCHOLINE M 3 MUSCARINIC RECEPTOR ANTAGONISTS
EP1648460A4 (en)	2009-04-01	ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
IL172911A0 (en)	2006-06-11	Muscarinic acetylcholine receptor antagonists
EP1613307A4 (en)	2008-03-12	M SB 3 / SB MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
IL172912A0 (en)	2006-06-11	Muscarinic acetylcholine receptor antagonists
PL370799A1 (en)	2005-05-30	Aminotetralin derivatives as muscarinic receptor antagonists
AU2002347552A1 (en)	2004-07-14	1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
IL173337A0 (en)	2006-06-11	Receptor
SG131946A1 (en)	2007-05-28	Ccr3 receptor antagonists
GB0203412D0 (en)	2002-04-03	5-HT 2B receptor antagonists
AU2003267802A1 (en)	2004-05-25	Quaternary ammonium compounds as muscarinic receptor antagonists
EP1636230A4 (en)	2010-06-16	ADENOSINE A1 RECEPTOR ANTAGONISTS
GB0302094D0 (en)	2003-02-26	EP4 receptor antagonists
GB0215389D0 (en)	2002-08-14	Receptor
AU2003249621A8 (en)	2003-12-12	Hemipteran muscarinic receptor
GB0321998D0 (en)	2003-10-22	Receptor
GB0307100D0 (en)	2003-04-30	Receptor
GB0329104D0 (en)	2004-01-21	Receptor